N-(3,4-Difluorophenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide

Catalog No. :
ACYZFJ456
CAS No. :
1775491-91-2
Molecular Formula :
C21H21F2N3O2
Molecular Weight :
385.41

IUPAC Name:N-(3,4-difluorophenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide

N-(3,4-Difluorophenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3,4-Difluorophenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide
IUPAC NameN-(3,4-difluorophenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide
Molecular FormulaC21H21F2N3O2
Molecular Weight385.41
SMILESO=C(C1=CC(N(C)C2N3CCCCC2)=C(C=C1)C3=O)NC4=CC=C(F)C(F)=C4
InChI KeyOKJCBUAMRLKTFZ-UHFFFAOYSA-N
SynonymN-(3,4-difluorophenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide;Azepino[2,1-b]quinazoline-3-carboxamide, N-(3,4-difluorophenyl)-5,5a,6,7,8,9,10,12-octahydro-5-methyl-12-oxo-
CAS No.1775491-91-2

Synthetic Route by SureRoute

1. ACYZFJ456 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRBGE701 route compound structure diagram
    ACRBGE70110117-64-3 In Stock
  4. Then
  5. ACYZFJ456 route product structure diagram
    ACYZFJ4561775491-91-2
Inquiry

2. ACYZFJ456 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRBGE701 route compound structure diagram
    ACRBGE70110117-64-3 In Stock
  4. Then
  5. ACYZFJ456 route product structure diagram
    ACYZFJ4561775491-91-2
Inquiry

Comments (0)